Overview

The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

Status:
Unknown status
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of MY-REPT capsule in primary, liver transplantation recipients
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Mycophenolate mofetil
Mycophenolic Acid